Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.
Kichul KoJianing WangStuart PerperYulei JiangDenisse YanezNatalya KaverinaJunting AiVladimir M LiarskiAnthony ChangYahui PengLi LanSusan WestmorelandLisa OlsonMaryellen L GigerLi Chun WangMarcus R ClarkPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2017)
These data demonstrate that Bcl-2 is an attractive therapeutic target in patients with lupus nephritis who manifest TII.